Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12904518 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
Conditions: Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia;   Postmenopause
Interventions: Drug: estrogen replacement therapy;   Drug: hormone replacement therapy;   Drug: estradiol;   Drug: medroxyprogesterone

Indicates status has not been verified in more than two years